# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 03-01-2024 | 12-31-2023 | 10-K | |
2 | 11-03-2023 | 10-01-2023 | 10-Q | |
3 | 08-02-2023 | 07-02-2023 | 10-Q | |
4 | 06-02-2023 | 04-02-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HSBC analyst Jeremy Fialko maintains Kenvue (NYSE:KVUE) with a Hold and raises the price target from $20 to $21.
Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data an...
Kenvue's first-quarter sales of $3.89 billion. Organic growth surged by 1.9% amidst strong demand in Self Care and Essentia...
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detect...